AAPM task group 224: Comprehensive proton therapy machine quality assurance.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 11 05 2019
revised: 13 05 2019
accepted: 14 05 2019
pubmed: 28 5 2019
medline: 23 1 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

 Task Group (TG) 224 was established by the American Association of Physicists in Medicine's Science Council under the Radiation Therapy Committee and Work Group on Particle Beams. The group was charged with developing comprehensive quality assurance (QA) guidelines and recommendations for the three commonly employed proton therapy techniques for beam delivery: scattering, uniform scanning, and pencil beam scanning. This report supplements established QA guidelines for therapy machine performance for other widely used modalities, such as photons and electrons (TG 142, TG 40, TG 24, TG 22, TG 179, and Medical Physics Practice Guideline 2a) and shares their aims of ensuring the safe, accurate, and consistent delivery of radiation therapy dose distributions to patients.  To provide a basis from which machine-specific QA procedures can be developed, the report first describes the different delivery techniques and highlights the salient components of the related machine hardware. Depending on the particular machine hardware, certain procedures may be more or less important, and each institution should investigate its own situation.  In lieu of such investigations, this report identifies common beam parameters that are typically checked, along with the typical frequencies of those checks (daily, weekly, monthly, or annually). The rationale for choosing these checks and their frequencies is briefly described. Short descriptions of suggested tools and procedures for completing some of the periodic QA checks are also presented.  Recommended tolerance limits for each of the recommended QA checks are tabulated, and are based on the literature and on consensus data from the clinical proton experience of the task group members. We hope that this and other reports will serve as a reference for clinical physicists wishing either to establish a proton therapy QA program or to evaluate an existing one.

Identifiants

pubmed: 31125441
doi: 10.1002/mp.13622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e678-e705

Informations de copyright

© 2019 American Association of Physicists in Medicine.

Auteurs

Bijan Arjomandy (B)

Karmanos Cancer Institute at McLaren-Flint, McLaren Proton Therapy Center, Flint, MI, USA.

Paige Taylor (P)

Imaging and Radiation Oncology Core (IROC) Houston, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Christopher Ainsley (C)

University of Pennsylvania, Philadelphia, PA, USA.

Sairos Safai (S)

Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.

Narayan Sahoo (N)

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Mark Pankuch (M)

Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.

Jonathan B Farr (JB)

Applications of Detectors and Accelerators to Medicine, 1217, Meyrin, Switzerland.

Sung Yong Park (S)

National Cancer Centre Singapore, Singapore, Singapore.

Eric Klein (E)

Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Jacob Flanz (J)

Massachusetts General Hospital, Burr Proton Therapy Center, Boston, MA.
Harvard Medical School, Cambridge, MA, USA.

Ellen D Yorke (ED)

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

David Followill (D)

Imaging and Radiation Oncology Core (IROC) Houston, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yuki Kase (Y)

Proton Therapy Division, Shizuoka Cancer Center, Shizuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH